With its anti-inflammatory properties, it helps the body fight off external pathogens
Less common Full Blood Count Markers (marked with*symbol) are not reported in Capillary/Home kit samples due to their instability

2-9 They do this by: Building confidence and self-efficacy by empowering patients to actively engage with their treatment journey Educating patients to address the widespread misconception that obesity is not a disease, with 40% of patients unaware of this and 80% feeling solely responsible for their condition Implementing a whole-health approach to redefine treatment success, focus on overall health outcomes, not just weight loss Setting realistic expectations which prepares patients for the possibility of losing less weight than expected while still achieving significant health benefits Supporting medication adherence by providing tools for reminders, routines, titration guidance, and addressing injection anxiety Driving medication persistence as a result of setting realistic expectations and frame treatment around long-term health gains rather than short-term weight loss Mitigating side effects through equipping patients to self-manage common side effects through proactive tracking and helping them connect the dots Want to learn even more about how digital solutions can unlock the full potential of GLP-1 therapies

Commercially insured T2D patients may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150/28-day supply) not available to Medicare Advantage or Medicaid enrollees
273279, journals.lww.com/co-endocrinology/fulltext/2023/12000/glucagon_like_peptide_1_receptor_agonists_and.2.aspx, Purwar, Ananya, and Shailesh Nagpure